SOUKYA launches Rs. 125 crore, 100-bed AYUSH hospital in Bengaluru
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
The offering is expected to close on November 10, 2025, subject to customary closing conditions
Relmada expects to initiate its Phase 3 program in the first half of 2026
Venus Remedies now has 29 active product approvals in Vietnam alone
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
Poviztra is a second brand of Wegovy
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Subscribe To Our Newsletter & Stay Updated